A Trial to Test the Safety and Efficacy of TEV-53408 in Participants With Vitiligo
- Study Title
- A Phase 1b, Open-Label Trial to Assess Safety and Exploratory Efficacy of TEV-53408 in Participants With Vitiligo
- Teva Identifier
- TV53408-IMM-10209
- ClinicalTrials.gov Identifier
- NCT06625177
- Study Status
- Recruiting
- Trial Condition(s)
- Vitiligo
- Interventions
- Drug: TEV-53408
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years to 75 Years
- Trial Duration
- November 11, 2024 - January 31, 2029
- Phase
- Phase 1